Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
20/07/2026 02:28
BRIEF-LTR Pharma Executes U.S. Commercial Agreement With Strive July 20 (Reuters) - LTR Pharma Ltd LTP.AX:
LTR EXECUTES U.S. COMMERCIAL AGREEMENT WITH STRIVE
EXECUTES DEFINITIVE U.S. COMMERCIAL AGREEMENT WITH STRIVE PHARMACY FOR ROXUS
AGREEMENT ESTABLISHES MANUFACTURING AND SUPPLY-CHAIN FRAMEWORK FOR ROXUS U.S. LAUNCH
Further company coverage: LTP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ltr Pharma
See all newsAustralia's LTR Pharma surges as its drug begins US prescription fulfillment
Brief: LTR Pharma Executes Exclusive Pilot Agreement With Marius Pharmaceuticals, Inc For Kyzatrex
Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
Australia's LTR Pharma rises on commercial tie-up with US telehealth firm
Australia's LT Pharma gains after nod to test nasal spray